Potentiating effect of estrogen in a patient with treatment-resistant depression
Berlanga, C.
Journal of Clinical Psychiatry 49(12): 504
1988
ISSN/ISBN: 0160-6689 PMID: 2848799 Document Number: 309844
Document emailed within 1 workday
Related Documents
Karadağ, F.; Tan, D.; Unal, F. 2011: Aripiprazole augmentation treatment in treatment resistant bipolar depression: two patient reports Turk Psikiyatri Dergisi 22(4): 269-272Kikkawa, F.; Kojima, M.; Oguchi, H.; Maeda, O.; Ishikawa, H.; Tamakoshi, K.; Mizuno, K.; Kawai, M.; Suganuma, N.; Tomoda, Y. 1993: Potentiating effect of amphotericin B on five platinum anticancer drugs in human cis-diamminedichloroplatinum (II) sensitive and resistant ovarian carcinoma cells Anticancer Research 13(4): 891-896
Rogóz, Z.; Skuza, G.; Wójcikowski, J.; Daniel, Władysława.A.; Wróbel, A.; Dudek, D.; Zieba, A. 2004: Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression Polish Journal of Pharmacology 56(6): 849-855
Marín, P.; Rovira, M.; Sanz, C.; Montserrat, E.; Rozman, C. 1990: Effect of the administration of rhGM-CSF in a patient with marrow aplasia resistant to immunosuppressive treatment Sangre 35(5): 397-399
Ballas, C.; Staab, J.P.; Evans, D.L. 2002: Strategies for treatment-resistant depression Psychopharmacology Bulletin 36(4): 39-62
Keller, M.B. 2005: Issues in treatment-resistant depression Journal of Clinical Psychiatry 66 Suppl. 8: 5-12
Taiminen, T. 2013: Treatment of drug-resistant depression Duodecim; Laaketieteellinen Aikakauskirja 129(20): 2149-2156
2011: Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice Prescrire International 20(116): 128-133
Lydiard, R.B. 1985: Tricyclic-resistant depression: treatment resistance or inadequate treatment? Journal of Clinical Psychiatry 46(10): 412-417
Devarajan, S.; Dursun, S.M. 2000: Citalopram plus reboxetine in treatment-resistant depression Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 45(5): 489-490
Wager, S.G.; Klein, D.F. 1988: Drug therapy strategies for treatment-resistant depression Psychopharmacology Bulletin 24(1): 69-74
Inoue, K. 2010: Cognitive-behavioral therapy for treatment-resistant depression Seishin Shinkeigaku Zasshi 112(11): 1097-1104
Fava, M. 2001: Augmentation and combination strategies in treatment-resistant depression Journal of Clinical Psychiatry 62(Suppl): 4-11
Jakuszkowiak-Wojten, K.; Gałuszko-Węgielnik, M.; Wilkowska, A.; Słupski, J.; Włodarczyk, A.; Górska, N.; Szarmach, J.; Szałach, Łu.P.; Wiglusz, M.S.; Krysta, K.; Cubała, W.ła.J. 2019: Suicidality in treatment resistant depression: perspective for ketamine use Psychiatria Danubina 31(Suppl 3): 258-260
Faust, V.; Hole, G.; Wolfersdorf, M. 1986: So-called therapy-resistant depression. Causes and treatment possibilities Fortschritte der Medizin 104(23-24): 465-468
Marangell, L.B. 2001: Switching antidepressants for treatment-resistant major depression Journal of Clinical Psychiatry 62(Suppl): 12-17
Kielholz, P. 1990: Treatment of drug-resistant depression by intravenous administration of antidepressants Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 90(4): 53-56
Kwak, S.; Tiller, D.; Tucker, P. 2015: Frontiers in Therapy of Treatment-Resistant-Depression: a Future Role of Ketamine? Journal of the Oklahoma State Medical Association 108(3): 88-89
Schaller, J.L.; Burkland, G.A.; Langhoff, P.J. 2007: Do bartonella infections cause agitation, panic disorder, and treatment-resistant depression? Medgenmed: Medscape General Medicine 9(3): 54
Krisanaprakornkit, T.; Paholpak, S.; Tassaniyom, K.; Pimpanit, V. 2010: Transcranial magnetic stimulation for treatment resistant depression: six case reports and review Journal of the Medical Association of Thailand 93(5): 580-586